Concourse Financial Group Securities’s PIMCO RAFI Multi-Factor International Equity ETF MFDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-816
Closed -$24.1K 2439
2021
Q3
$24K Hold
816
﹤0.01% 1601
2021
Q2
$24K Hold
816
﹤0.01% 1593
2021
Q1
$23K Buy
816
+350
+75% +$9.87K ﹤0.01% 1523
2020
Q4
$13K Sell
466
-199
-30% -$5.1K ﹤0.01% 1606
2020
Q3
$16K Buy
665
+199
+43% +$4.76K ﹤0.01% 1430
2020
Q2
$11K Sell
466
-68
-13% -$1.46K ﹤0.01% 1470
2020
Q1
$11K Sell
534
-276
-34% -$6.55K ﹤0.01% 1431
2019
Q4
$21K Buy
+810
New +$20.6K ﹤0.01% 1236
2019
Q3
Sell
-711
Closed -$17.4K 1993
2019
Q2
$18K Sell
711
-473
-40% -$11.6K ﹤0.01% 1288
2019
Q1
$29K Hold
1,184
﹤0.01% 1100
2018
Q4
$26K Buy
+1,184
New +$28.1K ﹤0.01% 1032

Other funds holding MFDX

Concourse Financial Group Securities's MFDX Position: Q4 2021 in Review

Concourse Financial Group Securities sold out of PIMCO RAFI Multi-Factor International Equity ETF (MFDX) in Q4 2021, closing a stake of 816 shares — an estimated $24.1K sold.

Concourse Financial Group Securities first reported a position in MFDX in Q4 2018 and held it in 11 quarters. The position peaked at $29K in Q1 2019. 8 funds tracked by Wall St. Rank hold MFDX as of Q4 2021.

  • Concourse Financial Group Securities reported no remaining PIMCO RAFI Multi-Factor International Equity ETF position as of Q4 2021 after selling out during the quarter.
  • Concourse Financial Group Securities sold 816 PIMCO RAFI Multi-Factor International Equity ETF shares in Q4 2021, an estimated $24.1K.
  • Concourse Financial Group Securities first reported a position in PIMCO RAFI Multi-Factor International Equity ETF in Q4 2018 and held it in 11 quarters.
  • Concourse Financial Group Securities's PIMCO RAFI Multi-Factor International Equity ETF position peaked at $29K in Q1 2019.
  • 8 funds tracked by Wall St. Rank held PIMCO RAFI Multi-Factor International Equity ETF as of Q4 2021.

Based on Concourse Financial Group Securities's 13F filing for Q4 2021, filed 7 Feb 2022.